Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Kidney Int ; 87(3): 535-42, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25354240

ABSTRACT

Hyperinsulinemia can contribute to hypertension through effects on sodium transport. To test whether the stimulatory effect of insulin on renal proximal tubule sodium transport is preserved in insulin resistance, we compared the effects of insulin on abdominal adipocytes and proximal tubules in rats and humans. Insulin markedly stimulated the sodium-bicarbonate cotransporter (NBCe1) activity in isolated proximal tubules through the phosphoinositide 3-kinase (PI3-K) pathway. Gene silencing in rats showed that while insulin receptor substrate (IRS)1 mediates the insulin effect on glucose uptake into adipocytes, IRS2 mediates the insulin effect on proximal tubule transport. The stimulatory effect of insulin on glucose uptake into adipocytes was severely reduced, but its stimulatory effect on NBCe1 activity was completely preserved in insulin-resistant Otsuka Long-Evans Tokushima Fatty (OLETF) rats and patients with insulin resistance. Despite widespread reduction of IRS1 and IRS2 expression in insulin-sensitive tissues, IRS2 expression in the kidney cortex was exceptionally preserved in both OLETF rats and patients with insulin resistance. Unlike liver, acute insulin injection failed to change the expression levels of IRS2 and sterol regulatory element-binding protein 1 in rat kidney cortex, indicating that regulatory mechanisms of IRS2 expression are distinct in liver and kidney. Thus, preserved stimulation of proximal tubule transport through the insulin/IRS2/PI3-K pathway may play an important role in the pathogenesis of hypertension associated with metabolic syndrome.


Subject(s)
Adipocytes/drug effects , Glucose/metabolism , Hypertension/etiology , Insulin Resistance/physiology , Insulin/pharmacology , Kidney Tubules, Proximal/drug effects , Sodium-Bicarbonate Symporters/drug effects , Adipocytes/metabolism , Aged , Animals , Female , Gene Silencing , Humans , Hypertension/metabolism , Insulin Receptor Substrate Proteins/genetics , Insulin Receptor Substrate Proteins/metabolism , Kidney Cortex/metabolism , Liver/metabolism , Male , Metabolic Syndrome/metabolism , Middle Aged , Phosphatidylinositol 3-Kinase/metabolism , RNA, Messenger/metabolism , Rats , Rats, Inbred OLETF , Rats, Wistar , Signal Transduction , Sodium-Bicarbonate Symporters/metabolism , Sterol Regulatory Element Binding Protein 1/metabolism
2.
J Am Soc Nephrol ; 25(7): 1523-32, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24511122

ABSTRACT

Stimulation of renal proximal tubule (PT) transport by angiotensin II (Ang II) is critical for regulation of BP. Notably, in rats, mice, and rabbits, the regulation of PT sodium transport by Ang II is biphasic: transport is stimulated by picomolar to nanomolar concentrations of Ang II but inhibited by nanomolar to micromolar concentrations of Ang II. However, little is known about the effects of Ang II on human PT transport. By functional analysis with isolated PTs obtained from nephrectomy surgery, we found that Ang II induces a dose-dependent profound stimulation of human PT transport by type 1 Ang II receptor (AT1)-dependent phosphorylation of extracellular signal-regulated kinase (ERK). In PTs of wild-type mice, the nitric oxide (NO) /cGMP/cGMP-dependent kinase II (cGKII) pathway mediated the inhibitory effect of Ang II. In PTs of cGKII-deficient mice, the inhibitory effect of Ang II was lost, but activation of the NO/cGMP pathway failed to phosphorylate ERK. Conversely, in human PTs, the NO/cGMP pathway mediated the stimulatory effect of Ang II by phosphorylating ERK independently of cGKII. These contrasting responses to the NO/cGMP pathway may largely explain the different modes of PT transport regulation by Ang II, and the unopposed marked stimulation of PT transport by high intrarenal concentrations of Ang II may be an important factor in the pathogenesis of human hypertension. Additionally, the previously unrecognized stimulatory effect of the NO/cGMP pathway on PT transport may represent a human-specific therapeutic target in hypertension.


Subject(s)
Angiotensin II/administration & dosage , Angiotensin II/physiology , Cyclic GMP/physiology , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/metabolism , Nitric Oxide/physiology , Signal Transduction/drug effects , Signal Transduction/physiology , Dose-Response Relationship, Drug , Humans , In Vitro Techniques
3.
Pflugers Arch ; 465(9): 1281-91, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23559100

ABSTRACT

Homozygous mutations in the electrogenic Na(+)-HCO3 (-) cotransporter NBCe1 cause proximal renal tubular acidosis (pRTA) associated with extrarenal manifestations such as ocular abnormalities and migraine. Previously, the NBCe1 cytosolic mutant S982NfsX4 was shown to have a dominant negative effect by forming hetero-oligomer complexes with wild type (WT), which might be responsible for the occurrence of glaucoma and migraine in the heterozygous family members. In this study, we investigated whether the NBCe1 L522P mutant has a similar dominant negative effect. Functional analyses in Xenopus oocytes and HEK293 cells revealed that the L522P mutant had no transport activity due to defective membrane expression. Furthermore, when coexpressed with WT, L522P significantly reduced the transport activity of WT. In HEK293 cells, the cytosolic mutant L522P reduced the membrane expression of NBCe1 by forming hetero-oligomer complexes with WT. Among the artificial Leu(522) mutants, L522I showed proper membrane expression and normal transport activity. However, the other mutants L522R, L522K, L522D, and L522E showed a predominant cytosolic retention. Moreover, L522R had a dominant negative effect, when coexpressed with WT. These results indicate that Leu(522) plays an important role in the structure and trafficking of NBCe1. They also suggest that the NBCe1 mutants retaining in cytoplasm may have the dominant negative effect in common, which may induce some clinical manifestations.


Subject(s)
Genes, Dominant , Genes, Recessive , Mutation, Missense , Sodium-Bicarbonate Symporters/metabolism , Animals , Cell Membrane/metabolism , Dogs , Endoplasmic Reticulum/metabolism , HEK293 Cells , Humans , Madin Darby Canine Kidney Cells , Protein Multimerization , Protein Structure, Tertiary , Protein Transport , Sodium-Bicarbonate Symporters/chemistry , Sodium-Bicarbonate Symporters/genetics , Xenopus
4.
Pflugers Arch ; 461(2): 249-59, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21234596

ABSTRACT

The electrogenic Na(+)-HCO(3)(-) cotransporter NBCe1 encoded by SLC4A4 plays essential roles in the regulation of intracellular/extracellular pH. Homozygous mutations in NBCe1 cause proximal renal tubular acidosis associated with ocular abnormalities. In the present study, we tried to perform functional characterization of the four nonsynonymous single nucleotide polymorphisms (SNPs), E122G, S356Y, K558R, and N640I in NBCe1A. Functional analysis in Xenopus oocytes revealed that while the K558R variant had a significantly reduced transport activity corresponding to 47% of the wild-type activity, the remaining variants E122G, S356Y, and N640I did not change the NBCe1A activity. Apparent Na(+) affinity of K558R was not different from that of wild-type NBCe1A. Immunohistological analyses in HEK293 cells and MDCK cells indicated that none of these SNPs changed the trafficking behaviors of NBCe1A. Functional analysis in HEK293 cells also revealed that only the K558R variant had a reduced transport activity, corresponding to 41-47% of the wild-type activity. From these results, we conclude that among four SNPs, only the K558R variant, which is predicted to lie in transmembrane segment 5, significantly reduces the NBCe1A activity without changing the trafficking behavior or the apparent extracellular Na(+) affinity.


Subject(s)
Sodium-Bicarbonate Symporters/genetics , Animals , Cells, Cultured , Dogs , HEK293 Cells , Humans , Oocytes/physiology , Polymorphism, Single Nucleotide , Sodium-Bicarbonate Symporters/physiology , Xenopus laevis
5.
World J Nephrol ; 3(4): 295-301, 2014 Nov 06.
Article in English | MEDLINE | ID: mdl-25374825

ABSTRACT

Renal tubules regulate blood pressure and humoral homeostasis. Mediators that play a significant role in regulating the transport of solutes and water include angiotensin II (AngII) and nitric oxide (NO). AngIIcan significantly raise blood pressure via effects on the heart, vasculature, and renal tubules. AngII generally stimulates sodium reabsorption by triggering sodium and fluid retention in almost all segments of renal tubules. Stimulation of renal proximal tubule (PT) transport is thought to be essential for AngII-mediated hypertension. However, AngII has a biphasic effect on in vitro PT transport in mice, rats, and rabbits: stimulation at low concentrations and inhibition at high concentrations. On the other hand, NO is generally thought to inhibit renal tubular transport. In PTs, NO seems to be involved in the inhibitory effect of AngII. A recent study reports a surprising finding: AngII has a monophasic stimulatory effect on human PT transport. Detailed analysis of signalling mechanisms indicates that in contrast to other species, the human NO/guanosine 3',5'-cyclic monophosphate/extracellular signal-regulated kinase pathway seems to mediate this effect of Ang II on PT transport. In this review we will discuss recent progress in understanding the effects of AngII and NO on renal tubular transport.

6.
Biomed Res Int ; 2014: 504808, 2014.
Article in English | MEDLINE | ID: mdl-24982885

ABSTRACT

Sodium-coupled bicarbonate absorption from renal proximal tubules (PTs) plays a pivotal role in the maintenance of systemic acid/base balance. Indeed, mutations in the Na(+)-HCO3 (-) cotransporter NBCe1, which mediates a majority of bicarbonate exit from PTs, cause severe proximal renal tubular acidosis associated with ocular and other extrarenal abnormalities. Sodium transport in PTs also plays an important role in the regulation of blood pressure. For example, PT transport stimulation by insulin may be involved in the pathogenesis of hypertension associated with insulin resistance. Type 1 angiotensin (Ang) II receptors in PT are critical for blood pressure homeostasis. Paradoxically, the effects of Ang II on PT transport are known to be biphasic. Unlike in other species, however, Ang II is recently shown to dose-dependently stimulate human PT transport via nitric oxide/cGMP/ERK pathway, which may represent a novel therapeutic target in human hypertension. In this paper, we will review the physiological and pathophysiological roles of PT transport.


Subject(s)
Acid-Base Equilibrium , Blood Pressure , Kidney Tubules, Proximal/metabolism , Acid-Base Equilibrium/drug effects , Angiotensin II/pharmacology , Animals , Biological Transport/drug effects , Blood Pressure/drug effects , Humans , Kidney Tubules, Proximal/drug effects , Metabolic Syndrome/metabolism , Metabolic Syndrome/physiopathology
7.
Cell Metab ; 13(5): 550-61, 2011 May 04.
Article in English | MEDLINE | ID: mdl-21531337

ABSTRACT

Thiazolidinediones (TZDs) improve insulin resistance by activating a nuclear hormone receptor, peroxisome proliferator-activated receptor γ (PPARγ). However, the use of TZDs is associated with plasma volume expansion through a mechanism that remains to be clarified. Here we showed that TZDs rapidly stimulate sodium-coupled bicarbonate absorption from the renal proximal tubule in vitro and in vivo. TZD-induced transport stimulation is dependent on PPARγ-Src-EGFR-ERK and observed in rat, rabbit and human, but not in mouse proximal tubules where Src-EGFR is constitutively activated. The existence of PPARγ-Src-dependent nongenomic signaling, which requires the ligand-binding ability, but not the transcriptional activity of PPARγ, is confirmed in mouse embryonic fibroblast cells. The enhancement of the association between PPARγ and Src by TZDs supports an indispensable role of Src in this signaling. These results suggest that the PPARγ-dependent nongenomic stimulation of renal proximal transport is also involved in TZD-induced volume expansion.


Subject(s)
Bicarbonates/metabolism , Kidney Tubules, Proximal/drug effects , Kidney Tubules, Proximal/metabolism , PPAR gamma/metabolism , Signal Transduction/drug effects , Sodium/metabolism , Thiazolidinediones/pharmacology , Adipocytes/cytology , Adipocytes/drug effects , Adipocytes/metabolism , Animals , Blotting, Western , Cation Transport Proteins/metabolism , Cell Differentiation/drug effects , Cells, Cultured , Embryo, Mammalian/cytology , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , ErbB Receptors/metabolism , Extracellular Signal-Regulated MAP Kinases/metabolism , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/metabolism , Humans , Immunoenzyme Techniques , Immunoprecipitation , Kidney Tubules, Proximal/cytology , Mice , Mice, Inbred C57BL , PPAR gamma/genetics , Phosphorylation/drug effects , Rabbits , Rats , Rats, Wistar , Sodium-Hydrogen Exchanger 1 , Sodium-Hydrogen Exchangers/metabolism , Species Specificity , src-Family Kinases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL